BIOMAT Database Logo BIOMAT Database Logo

Simultaneous pancreas-kidney transplantation in Hispanic recipients with type I diabetes mellitus and end-stage renal disease. 1997

G Ciancio, and G W Burke, and C Gomez, and L Olson, and V Esquenazi, and J Miller
Department of Surgery, University of Miami School of Medicine, FL 33101, USA.

UI MeSH Term Description Entries
D007676 Kidney Failure, Chronic The end-stage of CHRONIC RENAL INSUFFICIENCY. It is characterized by the severe irreversible kidney damage (as measured by the level of PROTEINURIA) and the reduction in GLOMERULAR FILTRATION RATE to less than 15 ml per min (Kidney Foundation: Kidney Disease Outcome Quality Initiative, 2002). These patients generally require HEMODIALYSIS or KIDNEY TRANSPLANTATION. ESRD,End-Stage Renal Disease,Renal Disease, End-Stage,Renal Failure, Chronic,Renal Failure, End-Stage,Chronic Kidney Failure,End-Stage Kidney Disease,Chronic Renal Failure,Disease, End-Stage Kidney,Disease, End-Stage Renal,End Stage Kidney Disease,End Stage Renal Disease,End-Stage Renal Failure,Kidney Disease, End-Stage,Renal Disease, End Stage,Renal Failure, End Stage
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D001786 Blood Glucose Glucose in blood. Blood Sugar,Glucose, Blood,Sugar, Blood
D002096 C-Peptide The middle segment of proinsulin that is between the N-terminal B-chain and the C-terminal A-chain. It is a pancreatic peptide of about 31 residues, depending on the species. Upon proteolytic cleavage of proinsulin, equimolar INSULIN and C-peptide are released. C-peptide immunoassay has been used to assess pancreatic beta cell function in diabetic patients with circulating insulin antibodies or exogenous insulin. Half-life of C-peptide is 30 min, almost 8 times that of insulin. Proinsulin C-Peptide,C-Peptide, Proinsulin,Connecting Peptide,C Peptide,C Peptide, Proinsulin,Proinsulin C Peptide
D003922 Diabetes Mellitus, Type 1 A subtype of DIABETES MELLITUS that is characterized by INSULIN deficiency. It is manifested by the sudden onset of severe HYPERGLYCEMIA, rapid progression to DIABETIC KETOACIDOSIS, and DEATH unless treated with insulin. The disease may occur at any age, but is most common in childhood or adolescence. Diabetes Mellitus, Brittle,Diabetes Mellitus, Insulin-Dependent,Diabetes Mellitus, Juvenile-Onset,Diabetes Mellitus, Ketosis-Prone,Diabetes Mellitus, Sudden-Onset,Diabetes, Autoimmune,IDDM,Autoimmune Diabetes,Diabetes Mellitus, Insulin-Dependent, 1,Diabetes Mellitus, Type I,Insulin-Dependent Diabetes Mellitus 1,Juvenile-Onset Diabetes,Type 1 Diabetes,Type 1 Diabetes Mellitus,Brittle Diabetes Mellitus,Diabetes Mellitus, Insulin Dependent,Diabetes Mellitus, Juvenile Onset,Diabetes Mellitus, Ketosis Prone,Diabetes Mellitus, Sudden Onset,Diabetes, Juvenile-Onset,Diabetes, Type 1,Insulin Dependent Diabetes Mellitus 1,Insulin-Dependent Diabetes Mellitus,Juvenile Onset Diabetes,Juvenile-Onset Diabetes Mellitus,Ketosis-Prone Diabetes Mellitus,Sudden-Onset Diabetes Mellitus
D003928 Diabetic Nephropathies KIDNEY injuries associated with diabetes mellitus and affecting KIDNEY GLOMERULUS; ARTERIOLES; KIDNEY TUBULES; and the interstitium. Clinical signs include persistent PROTEINURIA, from microalbuminuria progressing to ALBUMINURIA of greater than 300 mg/24 h, leading to reduced GLOMERULAR FILTRATION RATE and END-STAGE RENAL DISEASE. Diabetic Glomerulosclerosis,Glomerulosclerosis, Diabetic,Diabetic Kidney Disease,Diabetic Nephropathy,Intracapillary Glomerulosclerosis,Kimmelstiel-Wilson Disease,Kimmelstiel-Wilson Syndrome,Nodular Glomerulosclerosis,Diabetic Kidney Diseases,Glomerulosclerosis, Nodular,Kidney Disease, Diabetic,Kidney Diseases, Diabetic,Kimmelstiel Wilson Disease,Kimmelstiel Wilson Syndrome,Nephropathies, Diabetic,Nephropathy, Diabetic,Syndrome, Kimmelstiel-Wilson
D005260 Female Females
D005431 Florida State bounded on east by the Atlantic Ocean, on the south by the Gulf of Mexico, on the west by Alabama and on the north by Alabama and Georgia.
D005500 Follow-Up Studies Studies in which individuals or populations are followed to assess the outcome of exposures, procedures, or effects of a characteristic, e.g., occurrence of disease. Followup Studies,Follow Up Studies,Follow-Up Study,Followup Study,Studies, Follow-Up,Studies, Followup,Study, Follow-Up,Study, Followup

Related Publications

G Ciancio, and G W Burke, and C Gomez, and L Olson, and V Esquenazi, and J Miller
[Simultaneous pancreas-kidney transplantation for the treatment of type I diabetes with end-stage renal disease].
August 2000, Zhonghua wai ke za zhi [Chinese journal of surgery],
G Ciancio, and G W Burke, and C Gomez, and L Olson, and V Esquenazi, and J Miller
Type II diabetes after combined kidney and pancreas transplantation for type I diabetes mellitus and end-stage renal disease.
December 1996, Clinical transplantation,
G Ciancio, and G W Burke, and C Gomez, and L Olson, and V Esquenazi, and J Miller
Simultaneous pancreas-kidney transplantation for end-stage renal failure in type 1 diabetes mellitus: Current perspectives.
September 2023, World journal of transplantation,
G Ciancio, and G W Burke, and C Gomez, and L Olson, and V Esquenazi, and J Miller
Improved patient survival with simultaneous pancreas and kidney transplantation in recipients with diabetic end-stage renal disease.
June 2013, Diabetologia,
G Ciancio, and G W Burke, and C Gomez, and L Olson, and V Esquenazi, and J Miller
Persistent platelet activation after simultaneous pancreas-kidney transplantation (SPKT) in patients with end-stage renal disease (ESRD) and diabetes type I (DM-I).
April 2011, Thrombosis research,
G Ciancio, and G W Burke, and C Gomez, and L Olson, and V Esquenazi, and J Miller
Simultaneous pancreas and kidney transplantation as the standard surgical treatment for diabetes mellitus patients with end-stage renal disease.
February 2016, Hong Kong medical journal = Xianggang yi xue za zhi,
G Ciancio, and G W Burke, and C Gomez, and L Olson, and V Esquenazi, and J Miller
Effect of simultaneous pancreas-kidney transplantation on mortality of patients with type-1 diabetes mellitus and end-stage renal failure.
June 1999, Lancet (London, England),
G Ciancio, and G W Burke, and C Gomez, and L Olson, and V Esquenazi, and J Miller
Improved patient survival in recipients of simultaneous pancreas-kidney transplant compared with kidney transplant alone in patients with type 1 diabetes mellitus and end-stage renal disease.
September 2003, The British journal of surgery,
G Ciancio, and G W Burke, and C Gomez, and L Olson, and V Esquenazi, and J Miller
Simultaneous pancreas-kidney transplantation: The role in the treatment of type 1 diabetes and end-stage renal disease.
March 2014, Canadian Urological Association journal = Journal de l'Association des urologues du Canada,
G Ciancio, and G W Burke, and C Gomez, and L Olson, and V Esquenazi, and J Miller
Simultaneous pancreas/kidney transplantation--the optimal therapy for type I diabetics with end-stage renal disease in Europe, too?
January 1994, Transplant international : official journal of the European Society for Organ Transplantation,
Copied contents to your clipboard!